Marco Johannes Battista1, Kristina Goetze2, Marcus Schmidt3, Cristina Cotarelo4, Veronika Weyer-Elberich5, Annette Hasenburg3, Wolfgang Mueller-Klieser2, Stefan Walenta2. 1. Department of Gynecology and Obstetrics, University Medical Centre Mainz, Langenbeckstr. 1, 55131, Mainz, Germany. battist@uni-mainz.de. 2. Institute for Pathophysiology, University Medical Centre Mainz, Mainz, Germany. 3. Department of Gynecology and Obstetrics, University Medical Centre Mainz, Langenbeckstr. 1, 55131, Mainz, Germany. 4. Institute of Pathology, University Medical Centre Mainz, Mainz, Germany. 5. Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Centre Mainz, Mainz, Germany.
Abstract
PURPOSE: The precise determination of energy metabolites is challenged by the heterogeneity of their distribution, their rapid changes after surgical resection and the architectural complexity of malignancies. Induced metabolic bioluminescence imaging (imBI) allows to determine energy metabolites in tissue sections and to co-localize these with histological structures based on consecutive sections stained with HE. In this prospective pilot study patients with suspected advanced ovarian cancer (OC) were enrolled to prove the feasibility of imBI. METHODS: During surgery, suspicious peritoneal metastases were resected and transferred in liquid nitrogen within 30 s. ATP, glucose and lactate concentrations were measured. Furthermore, the expression of monocarboxylate transporters MCT1 and MCT4 was determined by immunofluorescence staining. RESULTS: 16 patients were screened, 12 entered the study. Final histological assessment revealed ten malignant and two benign peritoneal lesions. In all 12 cases high concentrations of ATP suggested that energy metabolism was not altered by the surgical and transport procedures (mean 0.56 μmol/g, range 0.24-1.21 μmol/g). The mean concentration of glucose was 1.95 μmol/g (range 0.58-4.71 μmol/g). The concentration of lactate was drastically higher in the ten OC cases (mean 24.79 μmol/g, range 17.51-37.16 μmol/g) compared to the benign samples (mean 5.98 μmol/g, range 5.43-6.54 μmol/g). Lactate concentrations seem to correlate with MCT1 (spearman rank correlation ρ = 0.624, 0.05 > p > 0.025), but not with MCT4 (spearman rank correlation ρ = 0.018, p > 0.1). CONCLUSIONS: ImBI is feasible in peritoneal metastases of OC and encourages further effort to elucidate the role of glucose, lactate, MCT1 and MCT4 in OC.
PURPOSE: The precise determination of energy metabolites is challenged by the heterogeneity of their distribution, their rapid changes after surgical resection and the architectural complexity of malignancies. Induced metabolic bioluminescence imaging (imBI) allows to determine energy metabolites in tissue sections and to co-localize these with histological structures based on consecutive sections stained with HE. In this prospective pilot study patients with suspected advanced ovarian cancer (OC) were enrolled to prove the feasibility of imBI. METHODS: During surgery, suspicious peritoneal metastases were resected and transferred in liquid nitrogen within 30 s. ATP, glucose and lactate concentrations were measured. Furthermore, the expression of monocarboxylate transporters MCT1 and MCT4 was determined by immunofluorescence staining. RESULTS: 16 patients were screened, 12 entered the study. Final histological assessment revealed ten malignant and two benign peritoneal lesions. In all 12 cases high concentrations of ATP suggested that energy metabolism was not altered by the surgical and transport procedures (mean 0.56 μmol/g, range 0.24-1.21 μmol/g). The mean concentration of glucose was 1.95 μmol/g (range 0.58-4.71 μmol/g). The concentration of lactate was drastically higher in the ten OC cases (mean 24.79 μmol/g, range 17.51-37.16 μmol/g) compared to the benign samples (mean 5.98 μmol/g, range 5.43-6.54 μmol/g). Lactate concentrations seem to correlate with MCT1 (spearman rank correlation ρ = 0.624, 0.05 > p > 0.025), but not with MCT4 (spearman rank correlation ρ = 0.018, p > 0.1). CONCLUSIONS: ImBI is feasible in peritoneal metastases of OC and encourages further effort to elucidate the role of glucose, lactate, MCT1 and MCT4 in OC.
Authors: Thomas Ziebart; Stefan Walenta; Martin Kunkel; Torsten E Reichert; Wilfried Wagner; Wolfgang Mueller-Klieser Journal: J Cancer Res Clin Oncol Date: 2010-04-11 Impact factor: 4.553
Authors: Kristina Goetze; Christian G Fabian; Andrea Siebers; Livia Binz; Daniel Faber; Stefano Indraccolo; Giorgia Nardo; Ulrike G A Sattler; Wolfgang Mueller-Klieser Journal: Cell Oncol (Dordr) Date: 2015-08-19 Impact factor: 6.730
Authors: Ulrike G A Sattler; Sandra S Meyer; Verena Quennet; Christian Hoerner; Hannah Knoerzer; Christian Fabian; Ala Yaromina; Daniel Zips; Stefan Walenta; Michael Baumann; Wolfgang Mueller-Klieser Journal: Radiother Oncol Date: 2009-12-28 Impact factor: 6.280
Authors: Ping-Chih Ho; Jessica Dauz Bihuniak; Andrew N Macintyre; Matthew Staron; Xiaojing Liu; Robert Amezquita; Yao-Chen Tsui; Guoliang Cui; Goran Micevic; Jose C Perales; Steven H Kleinstein; E Dale Abel; Karl L Insogna; Stefan Feske; Jason W Locasale; Marcus W Bosenberg; Jeffrey C Rathmell; Susan M Kaech Journal: Cell Date: 2015-08-27 Impact factor: 41.582
Authors: Manal Mehibel; Fernando Ortiz-Martinez; Nadine Voelxen; Amy Boyers; Amy Chadwick; Brian A Telfer; Wolfgang Mueller-Klieser; Catharine M West; Susan E Critchlow; Kaye J Williams; Ian J Stratford Journal: Sci Rep Date: 2018-11-14 Impact factor: 4.379